These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4185841)

  • 21. [Blood bacteriostatic activity in patients with tuberculosis of the urogenital system undergoing different methods of administration of antibacterial drugs].
    Gabinskiĭ BSh
    Probl Tuberk; 1971; 49(2):80-2. PubMed ID: 5105489
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of sodium para-aminosalicylate on the concentration of isoniazid (tubazid) in the blood of patients with tuberculosis].
    Kozulitsina TI; Korotaev GA
    Ter Arkh; 1969; 41(10):94-7. PubMed ID: 5359356
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of 3 antitubercular therapeutic programs comprising isoniazid with 4,4'-diisoamyloxythiocarbanilide. streptomycin and calcium-benzoyl-PAS].
    FAVEZ G; VULLIEMOZ P; BREAUD P
    Acta Tuberc Pneumol Belg; 1963; 54():103-9. PubMed ID: 14010281
    [No Abstract]   [Full Text] [Related]  

  • 24. Rapid determination of isonicotinic acid hydrazide in whole blood with 2,4,6-trinitrobenzenesulphonic acid.
    Dymond LC; Russell DW
    Clin Chim Acta; 1970 Mar; 27(3):513-20. PubMed ID: 5435232
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of different factors on the tolerance of antibacterial preparations by patients with pulmonary tuberculosis].
    Oĭfebakh MI; Simonian LK
    Probl Tuberk; 1970; 48(8):23-6. PubMed ID: 5496734
    [No Abstract]   [Full Text] [Related]  

  • 26. Modification of the serum isoniazid levels by different preparations of paraaminosalicylic acid.
    Tiitinen H; Mattila MJ
    Arzneimittelforschung; 1968 May; 18(5):623-5. PubMed ID: 5755895
    [No Abstract]   [Full Text] [Related]  

  • 27. [Determination of isoniazid in blood plasma].
    Bourdon R; Pollet J; Nicaise AM
    Ann Biol Clin (Paris); 1976; 34(2):127-31. PubMed ID: 9891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Active fraction of isonicotinic acid hydrazide in the blood of tuberculosis patients during its combined use with PAS].
    Dudchik GKh; Bilyk MA
    Vrach Delo; 1981 Feb; (2):77-8. PubMed ID: 7222619
    [No Abstract]   [Full Text] [Related]  

  • 29. [Differences between the protein binding of newborns and adults and their importance for pharmacological action].
    Ganshorn A; Kurz H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):117-8. PubMed ID: 4239156
    [No Abstract]   [Full Text] [Related]  

  • 30. [Concentration of tubazid, PAS and streptomycin in the blood and lung tissue in standard and intravenous administration].
    Kovalenko NN
    Vrach Delo; 1969 Oct; 10():134-5. PubMed ID: 5366785
    [No Abstract]   [Full Text] [Related]  

  • 31. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092
    [No Abstract]   [Full Text] [Related]  

  • 32. COMBINED DRUG THERAPY OF PULMONARY TUBERCULOSIS.
    BOESZOERMENYI M; FAUSZT I; KANITZ E; SCHWEIGER O
    Ther Hung; 1963; 12():9-14. PubMed ID: 14059821
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antibacterial therapy of pulmonary tuberculosis in the Bulgarian People's Republic and possibilities of its improvement].
    Dimitrov DA
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):342-3. PubMed ID: 5897865
    [No Abstract]   [Full Text] [Related]  

  • 34. [METHOD FOR EVALUATING THE STRENGTH OF SYNTHETIC ANTIBIOTICS IN THE BLOOD SERUM DURING CHEMOTHERAPY OF TUBERCULOSIS].
    OKAMOTO K; FUJINAGA R; YAMAUCHI H
    Kekkaku; 1963 Sep; 38():413-7. PubMed ID: 14056005
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative study (tolerance and effectiveness) of classic antituberculous therapy (P.A.S.-streptomycin-isoniazid) and a new combination (prothionamide-streptomycin-isoniazid)].
    Charpin J; Taranger J; Boutin C; Girbal JP
    Mars Med; 1969; 106(11):895-7. PubMed ID: 5407168
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pyrazinamide in association with streptomycin, PAS and isoniazid in the therapy of pulmonary tuberculosis].
    TODOROFF T; FRANZOSI P
    Minerva Med; 1962 Sep; 53():2667-73. PubMed ID: 13985260
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of 4 antibacterial preparations in the treatment of destructive tuberculosis of the lungs].
    Volkon VM; Shrentsel' OA
    Probl Tuberk; 1973; 51(6):28-31. PubMed ID: 4202910
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison between results of the dilution method and vertical diffusion method in determination of drug resistance in Mycobacterium tuberculosis].
    Nishimura T
    Iryo; 1970 Oct; 24(10):804-10. PubMed ID: 4991126
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ethambutol combined with streptomycin and isoniazid for the original treatment cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hayashi N; Hibino S
    Kekkaku; 1970 Feb; 45(2):55-60. PubMed ID: 5439133
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.